| |
| |
|
| Insider
Information: |
Falberg Kathryn E |
| Relationship: |
Director |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
909,461 |
|
|
Indirect Shares
|
402,106 |
|
|
| Direct
Value |
$55,043,981 |
|
|
|
Indirect Value
|
$9,081,276 |
|
|
| Total
Shares |
1,311,567 |
|
|
| Total
Value |
$64,125,256 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 48.2%
|
 -75.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
Director |
2016-05-04 |
358,253 |
2007-05-15 |
0 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
CFO and COO |
2009-06-16 |
0 |
|
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
EVP and CFO |
2014-03-05 |
133,387 |
2012-08-16 |
0 |
Premium* |
|
|
Medivation Inc |
MDVN |
Director |
2016-09-28 |
0 |
2016-09-28 |
0 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
Director |
2015-05-06 |
12,572 |
|
0 |
Premium* |
|
|
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2020-10-10 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2016-07-15 |
2,640 |
2016-07-15 |
0 |
Premium* |
|
|
Trade Desk, Inc. |
TTD |
Director |
2024-03-08 |
242,609 |
2024-03-08 |
50,000 |
Premium* |
|
|
Sio Gene Therapies Inc |
SIOX |
Director |
2017-04-17 |
53,937 |
2017-04-17 |
0 |
Premium* |
|
|
Arcus Biosciences Inc |
RCUS |
Director |
2023-06-15 |
46,900 |
2023-06-15 |
102,106 |
Premium* |
|
|
Tricida, Inc. |
TCDA |
Director |
2021-06-10 |
59,163 |
2018-07-02 |
0 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2022-11-30 |
0 |
2022-12-05 |
250,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
112 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and CFO |
• – – |
2013-12-11 |
4 |
AS |
$120.50 |
$361,500 |
D/D |
(3,000) |
128,721 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and CFO |
• – – |
2014-01-08 |
4 |
AS |
$131.82 |
$263,640 |
D/D |
(2,000) |
126,721 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP and CFO |
• – – |
2014-02-12 |
4 |
AS |
$157.00 |
$314,000 |
D/D |
(2,000) |
124,721 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2010-08-30 |
4 |
B |
$8.53 |
$219,127 |
I/I |
25,689 |
25,689 |
1.99 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2010-08-31 |
4 |
B |
$8.93 |
$217,097 |
I/I |
24,311 |
50,000 |
1.99 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP and CFO |
• – – |
2011-11-11 |
4 |
B |
$37.36 |
$112,080 |
I/I |
3,000 |
53,000 |
1.99 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2012-11-13 |
4 |
B |
$5.21 |
$260,500 |
D/D |
50,000 |
160,000 |
2.39 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2013-08-12 |
4 |
B |
$6.72 |
$335,935 |
D/D |
50,000 |
230,000 |
2.39 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2013-08-14 |
4 |
B |
$6.91 |
$345,710 |
D/D |
50,000 |
280,000 |
2.39 |
- |
|
| MDVN |
Medivation Inc |
Director |
– • – |
2015-02-27 |
4 |
B |
$116.51 |
$2,941,684 |
I/I |
25,000 |
25,000 |
2.1 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2015-08-11 |
4 |
B |
$16.00 |
$400,000 |
D/D |
25,000 |
94,894 |
2.39 |
- |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2016-11-14 |
4 |
B |
$25.99 |
$1,039,600 |
I/I |
40,000 |
40,000 |
2.1 |
- |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2016-11-14 |
4 |
B |
$25.92 |
$518,400 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2016-11-15 |
4 |
B |
$25.49 |
$509,800 |
D/D |
20,000 |
40,000 |
2.39 |
- |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2017-03-01 |
4 |
B |
$43.38 |
$867,664 |
I/I |
20,000 |
60,000 |
2.1 |
- |
|
| SIOX |
Sio Gene Therapies Inc |
Director |
– • – |
2017-04-17 |
4 |
B |
$18.54 |
$999,992 |
D/D |
53,937 |
53,937 |
2.39 |
- |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2017-06-15 |
4 |
B |
$48.06 |
$961,154 |
I/I |
20,000 |
80,000 |
2.1 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2018-02-26 |
4 |
B |
$32.00 |
$960,000 |
D/D |
30,000 |
124,894 |
2.39 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2018-03-19 |
4 |
B |
$15.00 |
$450,000 |
D/D |
30,000 |
80,504 |
2.39 |
- |
|
| TCDA |
Tricida, Inc. |
|
• • – |
2018-07-02 |
4 |
B |
$19.00 |
$600,001 |
D/D |
31,579 |
31,579 |
0.01 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2019-06-07 |
4 |
B |
$7.99 |
$176,297 |
I/I |
22,065 |
39,171 |
2.1 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2019-06-10 |
4 |
B |
$8.25 |
$82,500 |
I/I |
10,000 |
49,171 |
2.1 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2019-06-11 |
4 |
B |
$7.90 |
$79,000 |
I/I |
10,000 |
59,171 |
2.1 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2019-06-12 |
4 |
B |
$8.49 |
$84,928 |
I/I |
10,000 |
69,171 |
2.1 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2019-06-13 |
4 |
B |
$8.52 |
$110,152 |
I/I |
12,935 |
82,106 |
2.1 |
- |
|
112 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
